Publications by ASPIRE and Team Members

Mitchell SM, Pedersen HN, Eng Stime E, Sekikubo M, Moses E, Mwesigwa D, Biryabarema C, Christilaw J, Byamugisha JK, Money DM, Ogilvie GS. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity. BMC Womens Health. 2017 Jan 13;17(1):4.


Mitchell SM, Pedersen HN, Sekikubo M, Biryabarema C, Byamugisha JJ, Mwesigwa D, Steinberg M, Money DM, Ogilvie GS: Strategies for community education prior to clinical trial recruitment for a cervical cancer screening intervention in Uganda. Frontiers in Oncology. 2016; 6.


Moses E, Pedersen HN, Mitchell SM, Sekikubo M, Mwesigwa D, Singer J, Biryabarema C, Byamugisha JK, Money DM, Ogilvie GS. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: Preliminary results of a randomized controlled trial. Trop Med Int Health. 2015; 20(10):1355-67.


Teng FF, Mitchell SM, Sekikubo M, Biryabarema C, Byamugisha JK, Steinberg M, Money DM, Ogilvie GS. Understanding the role of embarrassment in gynaecological screening: a qualitative study from the ASPIRE cervical cancer screening project in Uganda. BMJ Open 2014;4:4 e004783.


Mitchell SM, Sekikubo M, Biryabarema C, Byamugisha JJ, Steinberg M, Jeronimo J, Money DM, Christilaw J, Ogilvie GS. Factors associated with high-risk HPV positivity in a low-resource setting in sub-Saharan Africa. Am J Obstet Gynecol 2014 Jan;210(1):81.e1-7.


Ogilvie G S, Mitchell S, Sekikubo M, Biryabarema C, Byamugisha J, Jeronimo J, Miller D, Steinberg M, Money D M. Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda. Int J Gynaecol Obstet 2013; 122 (2): 118–123.


Mitchell S, Ogilvie G, Steinberg M, Sekikubo M, Biryabarema C, Money D. Assessing women’s willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda. Int J Gynaecol Obstet 2011;114(2):111-115.


Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J. Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer.  Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095


Steben M, Jeronimo J, Wittet S, LaMontagne DS, Ogilvie G, Jensen C, Smith J, Franceschi S Upgrading Public Health Programs for Human Papillomavirus Prevention and Control is Possible in Low- and Middle-income Countries.  Vaccine 2012 10.1016/j.vaccine.2012.06.031


Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, Banzi R, van Kemenade FJ, Heideman DA, Meijer CJ.  High-risk HPV testing on self-sampled versus clinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening.  Int J Cancer 2012 Aug 21. doi: 10.1002/ijc.27790.


Ogilvie GS, Krajden M, van Niekerk DJ, Martin RE, Ehlen TG, Ceballos K et al. Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study. Br J Cancer 2012;107(12):1917-1924.


Ogilvie GS, Patrick DM, Schulzer M, Sellors JS, Petric M, Chambers K et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sexually Transmitted Infections. 2005; 81:207-212.


Ogilvie G, Krajden M, Maginley J, Isaac-Renton J, Hislop G, Elwood-Martin R et al. Feasibility of self-collection of specimens for human papillomavirus testing in hard-to reach women. CMAJ 2007;177(5):480-483.


Gunther OP, Ogilvie G, Naus M, Young E, Patrick DM, et al. Protecting the next generation: what is the role of the duration of human papillomavirus vaccine-related immunity? J Infect Dis.2008;197:1653–1661.


Other Key Publications

Zhao FH, Lewkowitz AK, Chen F, Lin MJ, Hu SY, Zhang X et al. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method. J Natl Cancer Inst 2012; 104(3):178-188.


Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC, Jr. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst 2010; 102(20):1557-1567.


Kuhn L, Wang C, Tsai WY, Wright TC, Denny L. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV infected women. AIDS 2010.


Gage JC, Rodriguez AC, Schiffman M, et al.. Treatability by cryotherapy in a screen-and-treat strategy. J Low Genit Tract Dis. 2009;13:174–181.


Louie KS, de Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Health.2009;14(10):1287–302.


Sherris J, Wittet S, Kleine A, Sellors J, Luciani S, Sankaranarayanan R, et al. Evidence-based, alternative cervical cancer screening approaches in low-resource settings. Int Perspectives Sexual Reprod Health. 2009;35:147–52.


World Health Organization. Global Health Risks: Mortality and burden of disease attributable to selected major risks. 2009.


Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008;16(32):41–49. doi: 10.1016/S0968-8080(08)32415-X.


Bais AG, van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voorhorst F, Babovic M, van Ballegooijen M, Helmerhorst TJ, Meijer CJ. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer. 2007;120:1505–1510.


Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TC, Jr. et al. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 2005; 294(17):2173-2181.


Chirenje ZM, Rusakaniko S, Kirumbi L, Ngwalle EW. Situation analysis for cervical cancer diagnosis and treatment in East. Central and Southern African countries. Bulletin of the World Health Organization. 2001;6:79.


Serwadda D, Wawer MJ, Shah KV, Sewankambo NK, Daniel R, et al. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. 1999. Journal of Infectious Diseases 180: 1316–1319.


Cuzick J, Bergeron C, von Knebel DM, Gravitt P, Jeronimo J, Lorincz AT et al. New technologies and procedures for cervical cancer screening. Vaccine 2012;30 Suppl 5:F107-F116.


Franco EL, de Sanjose S, Broker TR, Stanley MA, Chevarie-Davis M, Isidean SD et al. Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy. Vaccine 2012;30 Suppl 5:F175-F182.


Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmeron J, Uribe P, Velasco-Mondragon E et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011;378(9806):1868-1873.


Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla PP, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010. 11: 249-257


Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360(14):1385-1394.


Barata P, Mai V, Howlett R, Gagliardi A R, Stewart D E. Discussions about self-obtained samples for HPV testing as an alternative for cervical cancer prevention.  Journal of Psychosomatic Obstetrics & Gynecology 2008 29:4, 251-257